TransAct Technologies (TACT) CTO receives 14,124 RSU equity award

Rhea-AI Filing Summary

TransAct Technologies Chief Technology Officer Brent Richtsmeier reported an equity compensation grant. On February 25, 2026, he acquired 14,124 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated. These RSUs vest 25% each year, starting on the first anniversary of the grant date.

Following this filing, his directly held common stock position is 21,695 shares, and his RSU holdings total 14,124 units, reflecting his long-term, equity-based compensation alignment with the company.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Richtsmeier Brent

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	14,124	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 14,124 shares (Direct); Common Stock — 21,695 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Richtsmeier Brent

(Last) (First) (Middle)

2319 WHITNEY AVENUE

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								21,695	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/25/2026		A		14,124		(1)	(1)	Common Stock	14,124	$0(1)	14,124	D

Explanation of Responses:

1. Restricted Stock Units issued on February 25, 2026 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant.

	/s/ Steven A. DeMartino, Attorney-in-Fact for Brent Richtsmeier	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did TransAct Technologies (TACT) report for Brent Richtsmeier?

TransAct Technologies reported that Chief Technology Officer Brent Richtsmeier received a grant of 14,124 Restricted Stock Units on February 25, 2026. The grant reflects equity-based compensation under the company’s 2014 Equity Incentive Plan, as Amended and Restated, rather than an open-market stock purchase.

How many Restricted Stock Units did the TACT CTO receive in this Form 4?

The Chief Technology Officer of TransAct Technologies received 14,124 Restricted Stock Units. These RSUs were granted on February 25, 2026, as part of the company’s 2014 Equity Incentive Plan, as Amended and Restated, and represent a non-cash equity award tied to future vesting conditions.

What are the vesting terms of the 14,124 RSUs granted at TransAct Technologies (TACT)?

The 14,124 Restricted Stock Units vest in four equal installments of 25% each year. Vesting begins on the first anniversary of the February 25, 2026 grant date, meaning the award is structured to encourage longer-term retention and alignment with shareholder interests over several years.

Does the Form 4 show any stock sales by TransAct Technologies (TACT) CTO Brent Richtsmeier?

The Form 4 does not report any stock sales by the CTO. It shows an acquisition of 14,124 Restricted Stock Units as a grant and a reported direct ownership of 21,695 common shares after the transactions, indicating equity-based compensation rather than a disposition.

How many TransAct Technologies (TACT) common shares does the CTO hold after this filing?

After the reported transactions, the Chief Technology Officer directly holds 21,695 shares of TransAct Technologies common stock. In addition, he holds 14,124 Restricted Stock Units that are scheduled to vest 25% annually starting on the first anniversary of the February 25, 2026 grant.

Was the RSU grant to TransAct Technologies (TACT) CTO made under a specific equity plan?

Yes, the RSU grant was made under TransAct Technologies’ 2014 Equity Incentive Plan, as Amended and Restated. This plan governs the terms of equity awards such as Restricted Stock Units, including vesting schedules and other conditions tied to the company’s compensation framework.